$0.884950
0.011.72%
Last update: 2:06 PM
15 minutes delayed
Biotricity
BTCYNASDAQ
Biotricity (NASDAQ:BTCY) Stock, Analyst Ratings, Price Targets, Predictions
Biotricity Inc has a consensus price target of $3, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on July 5, 2023, February 15, 2023, and July 15, 2022. With an average price target of $2.67 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 201.34% upside for Biotricity Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Maxim Group
Lake Street
Northland Capital Markets
1calculated from analyst ratings
Analyst Ratings for Biotricity
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 11/20/2023 | Buy Now | — | HC Wainwright & Co. | Kevin Dede | — | Downgrade | Buy → Neutral | Get Alert |
| 07/05/2023 | Buy Now | 352% | HC Wainwright & Co. | Kevin Dede | $2 → $4 | Reiterates | Buy → Buy | Get Alert |
| 02/15/2023 | Buy Now | 126% | HC Wainwright & Co. | Kevin Dede | → $12 | Reiterates | → Buy | Get Alert |
| 07/15/2022 | Buy Now | — | Maxim Group | Allen Klee | — | Downgrade | Buy → Hold | Get Alert |
| 07/15/2022 | Buy Now | 126% | HC Wainwright & Co. | Kevin Dede | $36 → $12 | Maintains | Buy | Get Alert |
| 03/07/2022 | Buy Now | 465% | Lake Street | Frank Takkinen | → $30 | Initiates | → Buy | Get Alert |
| 11/23/2021 | Buy Now | 578% | HC Wainwright & Co. | Kevin Dede | — | Initiates | → Buy | Get Alert |
| 07/01/2021 | Buy Now | 691.01% | Northland Capital Markets | Jason Wittes | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Biotricity (BTCY) stock?
The latest price target for Biotricity (NASDAQ:BTCY) was reported by HC Wainwright & Co. on November 20, 2023. The analyst firm set a price target for $0.00 expecting BTCY to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Biotricity (BTCY)?
The latest analyst rating for Biotricity (NASDAQ:BTCY) was provided by HC Wainwright & Co., and Biotricity downgraded their neutral rating.
When was the last upgrade for Biotricity (BTCY)?
There is no last upgrade for Biotricity
When was the last downgrade for Biotricity (BTCY)?
The last downgrade for Biotricity Inc happened on November 20, 2023 when HC Wainwright & Co. changed their price target from N/A to N/A for Biotricity Inc.
When is the next analyst rating going to be posted or updated for Biotricity (BTCY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biotricity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biotricity was filed on November 20, 2023 so you should expect the next rating to be made available sometime around November 20, 2024.
Is the Analyst Rating Biotricity (BTCY) correct?
While ratings are subjective and will change, the latest Biotricity (BTCY) rating was a downgraded with a price target of $0.00 to $0.00. The current price Biotricity (BTCY) is trading at is $0.88, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.